How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

28,354 results for

Topical Corticosteroid

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

101. Updated evidence-based (S2e) European Dermatology Forum guideline on topical corticosteroids in pregnancy. Full Text available with Trip Pro

Updated evidence-based (S2e) European Dermatology Forum guideline on topical corticosteroids in pregnancy. Topical corticosteroids may be needed for treating skin conditions in pregnancy. Nevertheless, only limited data on the fetal effects of topical corticosteroids are available.To update an evidence-based guideline on the safe use of topical corticosteroids in pregnancy.A guideline subcommittee of the European Dermatology Forum updated the guideline by adding and appraising new evidence.The (...) current best evidence from 14 observational studies with 1 601 515 study subjects found no significant associations between maternal use of topical corticosteroids of any potency and some adverse pregnancy outcomes including mode of delivery, birth defect, preterm delivery and fetal death. However, maternal use of potent/very potent topical corticosteroids, especially in large amounts, is associated with an increase in the risk of low birthweight.Mild/moderate topical corticosteroids should

2017 Journal of the European Academy of Dermatology and Venereology

102. Ritonavir and Topical Ocular Corticosteroid Induced Cushing's Syndrome in an Adolescent with HIV-1 Infection. (Abstract)

Ritonavir and Topical Ocular Corticosteroid Induced Cushing's Syndrome in an Adolescent with HIV-1 Infection. Cushing's syndrome after topical ocular corticosteroid use is extremely rare. We describe a case of symptomatic Cushing's syndrome in an adolescent male with sight-threatening vernal keratoconjunctivitis on antiretroviral therapy for HIV-1 infection that included ritonavir, a potent cytochrome p450 CYP3A4 inhibitor. CYP3A4 inhibition reduces the metabolism of exogenous corticosteroids

2017 Pediatric Infectious Dsease Journal

103. Bilateral Morganella Morganii keratitis in a patient with facial topical corticosteroid-induced rosacea-like dermatitis: a case report. Full Text available with Trip Pro

Bilateral Morganella Morganii keratitis in a patient with facial topical corticosteroid-induced rosacea-like dermatitis: a case report. Bilateral keratitis rarely occurs in individuals without predisposing factors. Here we describe the clinical course of a patient who developed a bilateral keratitis caused by Morganella. morganii which might be associated with long term using of topical corticosteroids-containing preparations on the face.A 52-year-old female patient presented with marked (...) bilateral corneal infiltration and hypopyon without any usual predisposing factors for bilateral infectious keratitis. There was diffuse erythema with itching on face before the onset of eye discomforts. Microbiological culture of materials from both corneas revealed significant growth of Morganella morganii. Topical corticosteroid-induced rosacea-like dermatitis was diagnosed by dermatologist because of the characteristic eruptions and long history of using the corticosteroids-containing cosmetic

2017 BMC Ophthalmology

104. Evaluation of the influence of family and friends, and the Internet on patient perceptions of long-term topical corticosteroid use. (Abstract)

Evaluation of the influence of family and friends, and the Internet on patient perceptions of long-term topical corticosteroid use. Topical corticosteroids (TCS) are key to managing chronic inflammatory dermatoses (CID). Parents/patients cite TCS phobia as an impediment to treatment adherence. Family/friends and the Internet are a source of misinformation on TCS which can negatively impact perceptions of TCS safety.To assess information from family/friends and the Internet, as related (...) topical corticosteroids" (p < .001) and that "inflamed skin conditions will improve with the topical corticosteroids" (p = .007). Family/friends were more likely to recommend parents/patients "try non-prescription creams/ointments before resorting to the use of prescription topical corticosteroids" (p = .014).High rates of messages about TCS "risk" from family/friends and the Internet may affect patient/parent understanding about TCS safety. This may contribute to treatment non-adherence.

2017 Journal of Dermatological Treatment

105. Topical corticosteroids application in the evening is more effective than in the morning in psoriasis: comment. (Abstract)

Topical corticosteroids application in the evening is more effective than in the morning in psoriasis: comment. 28295615 2017 09 14 1468-3083 31 9 2017 Sep Journal of the European Academy of Dermatology and Venereology : JEADV J Eur Acad Dermatol Venereol Topical corticosteroids application in the evening is more effective than in the morning in psoriasis: comment. e405 10.1111/jdv.14214 Gu W-J WJ Department of Dermatology, General Hospital of Air Force, Beijing, China. Mi N N Hospital

2017 Journal of the European Academy of Dermatology and Venereology

106. Topical corticosteroids application in the evening is more effective than in the morning in psoriasis: in reply. (Abstract)

Topical corticosteroids application in the evening is more effective than in the morning in psoriasis: in reply. 28295619 2017 09 14 1468-3083 31 9 2017 Sep Journal of the European Academy of Dermatology and Venereology : JEADV J Eur Acad Dermatol Venereol Topical corticosteroids application in the evening is more effective than in the morning in psoriasis: in reply. e406-e407 10.1111/jdv.14216 Nguyen S S Department of Dermatology, Archet 2 Hospital, University Hospital of Nice, 06200, Nice

2017 Journal of the European Academy of Dermatology and Venereology

107. Topical corticosteroid phobia in atopic dermatitis: international feasibility study of the TOPICOP score. (Abstract)

Topical corticosteroid phobia in atopic dermatitis: international feasibility study of the TOPICOP score. Adherence to topical corticosteroids (TCS) is essential for the effective treatment of atopic dermatitis but can be limited by concerns about their use. This study examined the feasibility of applying the validated TOPICOP score for assessing TCS phobia across different countries.This was a prospective multicentre feasibility study conducted in 21 hospitals in 17 countries. Patients >3

2017 Allergy

108. Corticosteroids and Prophylaxis. What complications should you try to prevent in patients on chronic corticosteroids?

diagnosed with systemic sarcoidosis. The patient is started on prednisone 40mg with the plan to decrease the dose after remission of symptoms, which may take a number of months. What kind of prophylaxis should the patient receive? Corticosteroids are an effective treatment option for a number of diseases spanning many specialties. However, long-term corticosteroid treatment is marred with a number of side effects including hypertension, hyperglycemia, weight gain, adrenal suppression, osteoporosis, [1,2 (...) . However, there is limited data on the subject largely because, despite much notoriety, there is limited data to even show that corticosteroids actually cause peptic ulcers in the first place. Initial reports of an association date as far back as 1951 [14]. Since then, a multitude of trials followed by meta-analyses have reviewed the topic. In 1976, a meta-analysis of over 3558 patients from 26 prospective, randomized, double-blind, placebo-controlled trials found no difference in [15]. Another meta

2013 Clinical Correlations

109. Corticosteroid-Related Adverse Events Systematically Increase with Corticosteroid Dose in Noninfectious Intermediate, Posterior, or Panuveitis: Post Hoc Analyses from the VISUAL-1 and VISUAL-2 Trials. Full Text available with Trip Pro

was estimated controlling for time-dependent corticosteroid dose, age, sex, prior oral corticosteroid dose, prior topical corticosteroid use, and concomitant immunosuppressive drug use. Only patients randomized to placebo were considered.The primary outcome measure was the frequency of AEs.The incidence rates of corticosteroid-related AEs among placebo patients during the prednisone treatment period in VISUAL-1 was statistically higher than after discontinuation (454.2 per 100 patient-years [PY] vs. 36.1 (...) Corticosteroid-Related Adverse Events Systematically Increase with Corticosteroid Dose in Noninfectious Intermediate, Posterior, or Panuveitis: Post Hoc Analyses from the VISUAL-1 and VISUAL-2 Trials. Chronic use of corticosteroids for the treatment of uveitis has been linked with drug-associated toxicity and adverse events (AEs). This study examines the association between corticosteroid dosage and incidence rates of corticosteroid-related AEs.A post hoc analysis of the VISUAL-1 and VISUAL-2

2017 Ophthalmology Controlled trial quality: predicted high

110. Particulate Corticosteroid Versus Non-particulate Corticosteroid for Sacroiliac Joint Injection

(Participant) Primary Purpose: Treatment Official Title: Randomized Prospective Study of Particulate Corticosteroid Versus Non-particulate Corticosteroid for Sacroiliac Joint Steroid Injection Actual Study Start Date : September 14, 2017 Estimated Primary Completion Date : September 2020 Estimated Study Completion Date : September 2020 Resource links provided by the National Library of Medicine related topics: available for: Arms and Interventions Go to Arm Intervention/treatment Experimental (...) Particulate Corticosteroid Versus Non-particulate Corticosteroid for Sacroiliac Joint Injection Particulate Corticosteroid Versus Non-particulate Corticosteroid for Sacroiliac Joint Injection - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one

2017 Clinical Trials

111. Oral corticosteroids and asthma in children: Practical considerations. (Abstract)

is better in terms of efficacy, compared with a 3- to 5-day course of prednisone or prednisolone. Another interesting issue that has not been fully clarified concerns whether oral corticosteroids should be prescribed in preschoolers presenting with acute wheezing. The present review aims to review the most recent publications on this topic and to try to clarify which may be the best option in children suffering from asthma exacerbations.© 2020 EAACI and John Wiley and Sons A/S. Published by John Wiley (...) Oral corticosteroids and asthma in children: Practical considerations. Corticosteroids (CS) are among the most prescribed drugs in pediatrics. In allergy, CS are prescribed for several different conditions. If CS show clear benefits when adequately prescribed, CS are also associated with several side effects, well known by pediatricians. As for asthma exacerbations, the oral route is always the preferred one in pediatrics. Several authors debated if the use of a single dose of dexamethasone

2020 Pediatric Allergy and Immunology

112. Topical Corticosteroid

, propionato de halobetasol (sustancia) , propionato de halobetasol Derived from the NIH UMLS ( ) Ontology: Topical form corticosteroids (C0304604) Definition (NCI) Any synthetic steroid derivative exhibiting the same function as the naturally occurring corticosteroid hormone, formulated for topical application. Topical corticosteroids are applied to the skin where it exerts its effect, however, corticosteroids can be absorbed systemically after being applied locally. Topical corticosteroids are mainly (...) preparation , Topical form corticosteroids (product) , Topical form corticosteroids , Topical corticosteroid, NOS , Topical corticosteroid preparation (substance) , Topical corticosteroids (product) , Topical corticosteroids (substance) Spanish corticoesteroide de uso tópico (producto) , corticosteroide, forma farmacéutica tópica (producto) , corticoesteroide de uso tópico , corticoide, forma farmacéutica tópica , corticosteroide, forma farmacéutica tópica , preparado con corticosteroide, tópico

2018 FP Notebook

113. The safety of topical corticosteroids in atopic eczema: an overview of systematic reviews

The safety of topical corticosteroids in atopic eczema: an overview of systematic reviews Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing

2018 PROSPERO

114. Topical corticosteroids effective for nasal polyps

Topical corticosteroids effective for nasal polyps Topical corticosteroids effective for nasal polyps | Cochrane Primary Care Trusted evidence. Informed decisions. Better health. Enter terms Topical corticosteroids effective for nasal polyps Cochrane Trusted evidence. Informed decisions. Better health. Copyright © 2019 The Cochrane Collaboration | | We use cookies to improve your experience on our site.

2013 Cochrane PEARLS

115. Prescribing for rheumatological conditions in pregnancy and breastfeeding - Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids. Full Text available with Trip Pro

Prescribing for rheumatological conditions in pregnancy and breastfeeding - Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids. We use cookies to enhance your experience on our website. By continuing to use our website, you are agreeing to our use of cookies. You can change your cookie settings at any time. BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding—Part I: standard and biologic disease modifying anti-rheumatic drugs (...) and corticosteroids | Rheumatology | Oxford Academic Search Account Menu Menu Navbar Search Filter Mobile Microsite Search Term Close search filter search input Article Navigation Close mobile search navigation Article navigation September 2016 Article Contents Article Navigation BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding—Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids Julia Flint 1 Centre for Rheumatology Research, UCL Division of Medicine

2016 British Society for Rheumatology

116. Overcoming barriers to intranasal corticosteroid use in patients with uncontrolled allergic rhinitis Full Text available with Trip Pro

Overcoming barriers to intranasal corticosteroid use in patients with uncontrolled allergic rhinitis Patients suffering from allergic rhinitis often attempt to self-manage their symptoms and may seek advice from pharmacists about nonprescription product choices. Several drug classes, both prescription and over-the-counter (OTC), are available, including intranasal corticosteroids (INCSs); oral, intranasal, and ocular antihistamines; leukotriene antagonists; and topical and systemic

2017 Integrated pharmacy research & practice

117. Corticosteroid treatment of duchenne muscular dystrophy

Corticosteroid treatment of duchenne muscular dystrophy Practice guideline update summary: Corticosteroid treatment of Duchenne muscular dystrophy | Neurology Advertisement Search for this keyword Main menu User menu Search Search for this keyword The most widely read and highly cited peer-reviewed neurology journal Share February 02, 2016 ; 86 (5) Special Article Practice guideline update summary: Corticosteroid treatment of Duchenne muscular dystrophy Report of the Guideline Development (...) .), Loma Linda University Medical Center, CA; and Departments of Pediatric and Neurology/Neurosurgery (M.O.), McGill University, Montréal, Canada. Practice guideline update summary: Corticosteroid treatment of Duchenne muscular dystrophy David Gloss , Richard T. Moxley , Stephen Ashwal , Maryam Oskoui Neurology Feb 2016, 86 (5) 465-472; DOI: 10.1212/WNL.0000000000002337 Citation Manager Formats Make Comment See Comments Downloads 5504 Share Abstract Objective: To update the 2005 American Academy

2016 American Academy of Neurology

118. Predictive Factors in Response to Inhaled Corticoids in Chronic Cough

Predictive Factors in Response to Inhaled Corticoids in Chronic Cough Predictive Factors in Response to Inhaled Corticoids in Chronic Cough - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Predictive Factors (...) in Response to Inhaled Corticoids in Chronic Cough (FeNOTX) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02715167 Recruitment Status : Unknown Verified March 2016 by Cliniques universitaires Saint-Luc- Université Catholique de Louvain. Recruitment status was: Not yet recruiting First Posted : March 22

2016 Clinical Trials

119. Injection of Corticoids for the Treatment of Acute Sprains of the Proximal Interphalangeal Joints of the Fingers.

Library of Medicine related topics: Arms and Interventions Go to Arm Intervention/treatment Experimental: Diprophos Patients having had a sprain of the long fingers, within 2 weeks of consultation. This group will receive a single injection of corticoids. Drug: Diprophos Single subcutaneous injection of Diprophos, in the acute phase. No Intervention: Control group Patients having had a sprain of the long fingers (Eaton classification type I and II), within 2 weeks of consultation. This group (...) Injection of Corticoids for the Treatment of Acute Sprains of the Proximal Interphalangeal Joints of the Fingers. Injection of Corticoids for the Treatment of Acute Sprains of the Proximal Interphalangeal Joints of the Fingers. - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved

2016 Clinical Trials

120. Alternatives to systemic postnatal corticosteroids: Inhaled, nebulized and intratracheal. (Abstract)

Alternatives to systemic postnatal corticosteroids: Inhaled, nebulized and intratracheal. Concern about adverse outcomes with the use of systemic postnatal corticosteroids (PCS) for bronchopulmonary dysplasia (BPD) have led to the widespread use of alternative methods of administration in research and clinical care. Theoretically, administration of topical (directly to the lung) corticosteroids may allow for beneficial effects on the pulmonary system with a lower risk of undesirable side (...) effects compared with systemic administration. Current evidence suggests that inhaled corticosteroids may be an effective therapy in the management of developing BPD in preterm infants, but questions about their safety remain. An alternative to inhalation is the intratracheal administration of corticosteroids using surfactant as a vehicle, but this approach has only been studied in a limited number of infants. We review the evidence for the short-term clinical efficacy and safety of inhaled, nebulized

2019 Seminars in fetal & neonatal medicine

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>